Rosiglitazone (Standard)
Based on 1 Customer Validation
Rosiglitazone (Standard) is the analytical standard of Rosiglitazone. This product is intended for research and analytical applications. Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer.
For research use only. We do not sell to patients.
- Purity : 99.59%
- CAS No.: 122320-73-4
- Formula: C18H19N3O3S
- Molecular Weight:357.43
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 122320-73-4
-
Appearance Solid
-
Molecular Weight 357.43
-
Formula C18H19N3O3S
-
Color White to off-white
-
SMILES
O=C(N1)SC(CC2=CC=C(OCCN(C)C3=NC=CC=C3)C=C2)C1=O
-
Synonyms
BRL 49653 (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Rosiglitazone (Standard)
- 122320-73-4
- BRL 49653 (Standard)
- Reference Standards
- PPAR
- TRP Channel
- Autophagy
- Ferroptosis
- Apoptosis
- Peroxisome proliferator-activated receptors
- Transient receptor potential channels
- PPARγ
- antihyperglycemic
- neuroprotection
- diabetic
- diabetes
- mellitus
- bladder
- cancer
- hepatocellular
- carcinoma
- HCC
- smoke
- senescence
- ovarian cancer
- Inhibitor
- inhibitor
- inhibit